22.07.2015 • NewsDede WillamsPfizerRoche

Pfizer Ranked Top Foreign Firm in UK Academic Research

US drugmaker Pfizer has more collaborations with British universities than any other foreign company, according to the newly published Dowling Review conducted by Ann Dowling, president of the Royal Academy of Engineering.

The business daily Financial Times (FT) commented that the review sheds new light on Pfizer’s role in the UK science base a year after it was defeated in a bitter battle to buy AstraZeneca. It recalls that fears Pfizer would cut jobs and scrap research at the UK pharmaceuticals group fueled political opposition to the proposed £69.4 billion deal.

In the discussion about Pfizer’s grab for AstraZeneca, the US company’s commitment to the UK was questioned. It was pointed out that the drugmaker cut thousands of jobs four years earlier at its former research and development center in Sandwich, Kent, where the blockbuster erectile dysfunction treatment Viagra was discovered.

Pfizer said it was proud that its support for “world class science in the UK” had been recognized by the review. Analysts have speculated that the pharmaceutical giant, still flush with cash, may return to Britain for another raid on one of the country’s biggest drugs groups, possibly Glaxo SmithKline (GSK).

According to the Dowling Review, two-thirds of the 40 companies with the greatest number of collaborations with UK universities are based overseas. In pharmaceuticals, these include Bayer and Roche.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.